2335 Stock Chart & Stats
$30.50
-$0.38(-1.23%)
―
--
Day’s Range― - ―
52-Week Range$27.00 - $45.04
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
HK$8.04B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta4.62
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding280,071,100
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H News
2335 FAQ
What was Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s price range in the past 12 months?
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H lowest stock price was $27.00 and its highest was $45.04 in the past 12 months.
What is Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s market cap?
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s market cap is HK$8.04B.
When is Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s earnings last quarter?
Currently, no data Available
Is Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H overvalued?
According to Wall Street analysts Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s price is currently Undervalued.
Does Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H pay dividends?
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H does not currently pay dividends.
What is Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s EPS estimate?
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H have?
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H has 280,071,100 shares outstanding.
What happened to Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2335
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H
Shaanxi Mycotech Pharmaceutical Technology Co., Ltd. operates as a platform-based biotechnology company dedicated to accelerating the global innovation and development of next-generation bi-multi-specific peptide drugs. Its products include MT1013, which is a dual-targeting receptor agonist polypeptide that simultaneously targets the CaSR and the OGP receptor. It is designed for the treatment of SHPT, CKD-MBD with Osteoporosis and SHPT not on Dialysis. The company was founded by Wang Bing on January 19, 2007 and is headquartered in Xi'an, China.